Results 1 to 10 of about 249,029 (275)
The anaemia of Plasmodium vivax malaria [PDF]
Malaria Journal, 2012 Plasmodium vivax threatens nearly half the world's population and is a significant impediment to achievement of the millennium development goals. It is an important, but incompletely understood, cause of anaemia. This review synthesizes current evidence on the epidemiology, pathogenesis, treatment and consequences of vivax-associated anaemia.
Pierre Buffet +8 more
openaire +7 more sources
Vivax Malaria: Neglected and Not Benign [PDF]
The American Journal of Tropical Medicine and Hygiene, 2007 Plasmodium vivax threatens almost 40% of the world’s population, resulting in 132–391 million clinical infections each year. Most of these cases originate from Southeast Asia and the Western Pacific, although a significant number also occurs in Africa and South America.
Price, R +5 more
openaire +5 more sources
Costs Associated with Malaria in Pregnancy in the Brazilian Amazon, a Low Endemic Area Where Plasmodium vivax Predominates. [PDF]
, 2016 BACKGROUND: Information on costs associated with malaria in pregnancy (MiP) in low transmission areas where Plasmodium vivax predominates is so far missing. This study estimates health system and patient costs of MiP in the Brazilian Amazon.
Bardají, A +7 more
core +8 more sources
Plasmodium vivax Hospitalizations in a Monoendemic Malaria Region: Severe Vivax Malaria? [PDF]
The American Society of Tropical Medicine and Hygiene, 2014 Severe malaria caused by Plasmodium vivax is no longer considered rare. To describe its clinical features, we performed a retrospective case control study in the subregion of Luciano Castillo Colonna, Piura, Peru, an area with nearly exclusive vivax malaria transmission.
Quispe, Antonio M. +7 more
openaire +4 more sources
Adequate Primaquine for Vivax Malaria [PDF]
Journal of Travel Medicine, 2006 Treatment of vivax malaria with primaquine prevents the relapse of infection from residual liver stages of the parasite. Inadequate dosage is related to a higher relapse risk.A comparison was made of vivax malaria relapse-prevention treatments with primaquine 22.5 mg or 30 mg daily for 14 days on 146 reports to the Australian Army Central Malaria ...
Kitchener, S. +3 more
openaire +4 more sources
Plasmodium vivax-like genome sequences shed new insights into Plasmodium vivax biology and evolution [PDF]
, 2018 Although Plasmodium vivax is responsible for the majority of malaria infections outside Africa, little is known about its evolution and pathway to humans. Its closest genetic relative, P.
Arnathau, Céline +15 more
core +4 more sources
Plasmodium vivax Malaria in Cambodia [PDF]
The American Journal of Tropical Medicine and Hygiene, 2016 The Cambodian National Strategic Plan for Elimination of Malaria aims to move step by step toward elimination of malaria across Cambodia with an initial focus on Plasmodium falciparum malaria before achieving elimination of all forms of malaria, including Plasmodium vivax in 2025. The emergence of artemisinin-resistant P. falciparum in western Cambodia
Siv, Sovannaroth +9 more
openaire +4 more sources
, 2003 BACKGROUND: Despite a relatively good national case reporting system in Sri Lanka, detailed maps of malaria distribution have not been publicly available.
Amerasinghe, Felix P +3 more
core +3 more sources
The pathophysiology of vivax malaria
Trends in Parasitology, 2009 Long considered a benign infection, Plasmodium vivax is now recognized as a cause of severe and fatal malaria, despite its low parasite biomass, the increased deformability of vivax-infected red blood cells and an apparent paucity of parasite sequestration.
Nicholas M. Anstey +6 more
openaire +4 more sources
An improved Plasmodium cynomolgi genome assembly reveals an unexpected methyltransferase gene expansion. [PDF]
, 2017 Background: Plasmodium cynomolgi, a non-human primate malaria parasite species, has been an important model parasite since its discovery in 1907. Similarities in the biology of P.
Berriman, Matt +7 more
core +2 more sources